Teprotumumab-trbw as a Novel Monoclonal Antibody for Thyroid Eye Disease: A Literature Review

Thyroid eye disease (TED) can cause disfigurement and vision loss, most commonly in patients with Graves’ disease. These symptoms are related to orbital inflammation subsequently cause proptosis and limited eye movement. Traditionally, TED is treated with corticosteroids to decrease inflammation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bocklud, Brooke E, Fakhre, Waddih, Murphy, Brennen, Maddox, Kirsten, Ahmadzadeh, Shahab, Viswanath, Omar, Varrassi, Giustino, Shekoohi, Sahar, Kaye, Alan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511347/
https://www.ncbi.nlm.nih.gov/pubmed/37746376
http://dx.doi.org/10.7759/cureus.43878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511347/
https://www.ncbi.nlm.nih.gov/pubmed/37746376
http://dx.doi.org/10.7759/cureus.43878

Ejemplares similares